Announcements

21 November 2024
Current Oncology | National Pancreatic Cancer Awareness Month


November is National Pancreatic Cancer Awareness Month, dedicated to raising awareness, supporting patients, and advancing research for better diagnosis and treatments. We would like to take this opportunity to express our gratitude to all of the researchers who have contributed to this field. In particular, we would like to share some of the innovative research findings in the related fields, published in Current Oncology (ISSN: 1718-7729). We hope this announcement will provide useful information for this field.

Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review
by Milly Buwenge, Alessandra Arcelli, Francesco Cellini, Francesco Deodato, Gabriella Macchia, Savino Cilla, Erika Galietta, Lidia Strigari, Claudio Malizia, Silvia Cammelli et al.
Curr. Oncol. 2022, 29(4), 2616-2629; https://doi.org/10.3390/curroncol29040214

Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies
by Miguel A. Ortega, Leonel Pekarek, Oscar Fraile-Martinez, Cielo Garcia-Montero, Miguel A. Saez, Angel Asúnsolo, Miguel A. Alvarez-Mon, Jorge Monserrat, Lidia Ruiz-Llorente, Natalio García-Honduvilla et al.
Curr. Oncol. 2022, 29(4), 2442-2453; https://doi.org/10.3390/curroncol29040198

Prognostic Impact of Resection Margin Status on Distal Pancreatectomy for Ductal Adenocarcinoma
by Maia Blomhoff Holm and Caroline Sophie Verbeke
Curr. Oncol. 2022, 29(9), 6551-6563; https://doi.org/10.3390/curroncol29090515

Preoperative C-Reactive Protein-to-Albumin Ratio Predicts Postoperative Pancreatic Fistula following Pancreatoduodenectomy: A Single-Center, Retrospective Study
by Naotake Funamizu, Takeshi Utsunomiya, Masahiko Honjo, Chihiro Ito, Mikiya Shine, Mio Uraoka, Tomoyuki Nagaoka, Kei Tamura, Katsunori Sakamoto, Kohei Ogawa et al.
Curr. Oncol. 2022, 29(12), 9867-9874; https://doi.org/10.3390/curroncol29120775

Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights
by Rita Balsano, Valentina Zanuso, Angelo Pirozzi, Lorenza Rimassa and Silvia Bozzarelli
Curr. Oncol. 2023, 30(4), 3871-3885; https://doi.org/10.3390/curroncol30040293

An Overview of Pancreatic Neuroendocrine Tumors and an Update on Endoscopic Techniques for Their Management
by Osama O. Elkelany, Fred G. Karaisz, Benjamin Davies and Somashekar G. Krishna
Curr. Oncol. 2023, 30(8), 7566-7580; https://doi.org/10.3390/curroncol30080549

Radiotherapy for Locally Advanced Pancreatic Adenocarcinoma—A Critical Review of Randomised Trials
by Mathilde Weisz Ejlsmark, Tine Schytte, Uffe Bernchou, Rana Bahij, Britta Weber, Michael Bau Mortensen and Per Pfeiffer
Curr. Oncol. 2023, 30(7), 6820-6837; https://doi.org/10.3390/curroncol30070499

Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms
by Jasmeet Kaur and Namrata Vijayvergia
Curr. Oncol. 2023, 30(9), 8653-8664; https://doi.org/10.3390/curroncol30090627

You are welcome to submit relevant papers to the journal Current Oncology. For any questions, please feel free to contact us.

Current Oncology Editorial Office

More News...
Back to TopTop